Vycor Medical (VYCO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 17.54% |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -32.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.93% |
| Dec 31, 2025 | 18.68% |
| Sep 30, 2025 | 17.20% |
| Jun 30, 2025 | 30.87% |
| Mar 31, 2025 | 5.35% |
| Dec 31, 2024 | 66.98% |
| Sep 30, 2024 | -11.89% |
| Jun 30, 2024 | -2.31% |
| Mar 31, 2024 | 21.93% |
| Dec 31, 2023 | 22.56% |
| Sep 30, 2023 | 15.94% |
| Jun 30, 2023 | 31.52% |
| Mar 31, 2023 | 22.77% |
| Dec 31, 2022 | 19.21% |
| Sep 30, 2022 | 9.35% |
| Jun 30, 2022 | 18.85% |
| Mar 31, 2022 | 11.58% |
| Dec 31, 2021 | 27.06% |
| Sep 30, 2021 | 20.41% |
| Jun 30, 2021 | 71.81% |